CA2584130A1 - High cell density process for growth of listeria - Google Patents
High cell density process for growth of listeria Download PDFInfo
- Publication number
- CA2584130A1 CA2584130A1 CA002584130A CA2584130A CA2584130A1 CA 2584130 A1 CA2584130 A1 CA 2584130A1 CA 002584130 A CA002584130 A CA 002584130A CA 2584130 A CA2584130 A CA 2584130A CA 2584130 A1 CA2584130 A1 CA 2584130A1
- Authority
- CA
- Canada
- Prior art keywords
- listeria
- culture
- protein
- medium
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001122—Ephrin Receptors [Eph]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62013304P | 2004-10-18 | 2004-10-18 | |
| US60/620,133 | 2004-10-18 | ||
| PCT/US2005/038237 WO2006045110A2 (en) | 2004-10-18 | 2005-10-18 | High cell density process for growth of listeria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2584130A1 true CA2584130A1 (en) | 2006-04-27 |
Family
ID=36203744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002584130A Abandoned CA2584130A1 (en) | 2004-10-18 | 2005-10-18 | High cell density process for growth of listeria |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060121053A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1802338A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008516614A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005295158A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2584130A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006045110A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8956621B2 (en) | 1994-11-08 | 2015-02-17 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical dysplasia |
| US7820180B2 (en) * | 2004-09-24 | 2010-10-26 | The Trustees Of The University Of Pennsylvania | Listeria-based and LLO-based vaccines |
| US7662396B2 (en) * | 2001-03-26 | 2010-02-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US8791237B2 (en) * | 1994-11-08 | 2014-07-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of non-hodgkins lymphoma |
| US7794729B2 (en) * | 1994-11-08 | 2010-09-14 | The Trustees Of The University Of Pennsylvania | Methods and compositions for immunotherapy of cancer |
| US8114414B2 (en) | 1994-11-08 | 2012-02-14 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical cancer |
| US6051237A (en) * | 1994-11-08 | 2000-04-18 | The Trustees Of The University Of Pennsylvania | Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| JP2004500405A (ja) * | 2000-03-29 | 2004-01-08 | ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア | 抗原の免疫原性を増強するための組成物および方法 |
| US7700344B2 (en) * | 2001-03-26 | 2010-04-20 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US8771702B2 (en) | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| WO2007061848A2 (en) * | 2005-11-17 | 2007-05-31 | The Trustees Of The University Of Pennsylvania | Methods for producing, growing, and preserving listeria vaccine vectors |
| EP2056849A4 (en) * | 2006-08-04 | 2010-09-08 | Univ Pennsylvania | METHOD AND COMPOSITIONS FOR TREATING IGE-MEDIATED ILLNESSES |
| US8241636B2 (en) * | 2006-08-15 | 2012-08-14 | The Trustees Of The University Of Pennsylvania | Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| US8268326B2 (en) * | 2006-08-15 | 2012-09-18 | The Trustees Of The University Of Pennsylvania | Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| JP5757863B2 (ja) | 2008-05-19 | 2015-08-05 | アドバクシス インコーポレイテッド | 異種抗原のための二重送達システム |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| US8778329B2 (en) | 2009-03-04 | 2014-07-15 | The Trustees Of The University Of Pennsylvania | Compositions comprising angiogenic factors and methods of use thereof |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| AU2011223789A1 (en) | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| CN107412756A (zh) | 2010-10-01 | 2017-12-01 | 宾夕法尼亚大学理事会 | 李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途 |
| CA2829960A1 (en) | 2011-03-11 | 2012-09-20 | John Rothman | Listeria-based adjuvants |
| BR112014022662A2 (pt) | 2012-03-12 | 2017-10-03 | Advaxis Inc | Inibição da função de célula supressora seguindo tratamento de vacina de listeria |
| AU2015250111A1 (en) * | 2014-04-24 | 2016-12-08 | Advaxis, Inc. | Recombinant listeria vaccine strains and methods of producing the same |
| EP3313975A4 (en) * | 2015-06-24 | 2019-03-13 | Advaxis, Inc. | MANUFACTURING DEVICE AND METHOD FOR PERSONALIZED ADMINISTRATION OF VECTOR-BASED IMMUNOTHERAPY |
| US10774390B2 (en) * | 2015-09-02 | 2020-09-15 | The Regents Of The University Of California | Methods and compositions for modulating PrfA mediated virulence gene activation in Listeria spp |
| US20180325964A1 (en) * | 2015-11-20 | 2018-11-15 | Advaxis, Inc. | Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain |
| JP7284156B2 (ja) * | 2017-09-19 | 2023-05-30 | アドバクシス, インコーポレイテッド | 細菌またはListeria株の凍結乾燥のための組成物および方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6051237A (en) * | 1994-11-08 | 2000-04-18 | The Trustees Of The University Of Pennsylvania | Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| US6927203B1 (en) * | 1999-08-17 | 2005-08-09 | Purdue Research Foundation | Treatment of metastatic disease |
| US7425449B2 (en) * | 2002-04-30 | 2008-09-16 | The Regents Of The University Of California | Site specific Listeria integration vectors and methods for using the same |
| US20050152899A1 (en) * | 2002-05-10 | 2005-07-14 | Kinch Michael S. | EphA2 agonistic monoclonal antibodies and methods of use thereof |
| EP1519956B1 (en) * | 2002-05-10 | 2011-09-21 | Medimmune, Inc. | Epha2 monoclonal antibodies and methods of use thereof |
| EP1575509B1 (en) * | 2002-05-10 | 2011-10-26 | Purdue Research Foundation | Epha2 agonistic monoclonal antibodies and methods of use thereof |
| JP2006507256A (ja) * | 2002-09-24 | 2006-03-02 | ザ バーナム インスティチュート | Eph受容体活性を調節する新規薬剤 |
| ATE552843T1 (de) * | 2003-02-06 | 2012-04-15 | Aduro Biotech | Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen |
| EP1618184A4 (en) * | 2003-04-11 | 2006-06-21 | Medimmune Inc | EPHA2, HYPOPROLIFERATIVE CELL DISORDERS, AND EPITHELIAL AND ENDOTHELIAL RECONSTITUTION |
| EP1617864A4 (en) * | 2003-04-11 | 2006-06-21 | Medimmune Inc | EPHA2 AND NON-NEOPLASTIC HYPERPROLIFERATIVE CELL TROUBLESHOOTING |
| US20050147593A1 (en) * | 2003-05-22 | 2005-07-07 | Medimmune, Inc. | EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders |
| CA2533789C (en) * | 2003-07-30 | 2013-09-17 | University Of Pittsburgh Of The Commnonwealth System Of Higher Education | Epha2 t-cell epitope agonists and uses therefor |
| EP1660186B1 (en) * | 2003-08-18 | 2013-12-25 | MedImmune, LLC | Humanization of antibodies |
| US20050042664A1 (en) * | 2003-08-22 | 2005-02-24 | Medimmune, Inc. | Humanization of antibodies |
| KR20060130038A (ko) * | 2003-10-15 | 2006-12-18 | 메디뮨 인코포레이티드 | 리스테리아에 의거한 EphA2 백신 |
| US20050153923A1 (en) * | 2003-12-04 | 2005-07-14 | Kinch Michael S. | Targeted drug delivery using EphA2 or EphA4 binding moieties |
| EP1773391A4 (en) * | 2004-06-25 | 2009-01-21 | Medimmune Inc | INCREASING THE PRODUCTION OF RECOMBINANT ANTIBODIES IN MAMMALIAN CELLS BY MUTAGENESIS ON THE SITE |
| AU2005277641A1 (en) * | 2004-08-16 | 2006-03-02 | Medimmune, Llc | Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| EP1812077A4 (en) * | 2004-10-27 | 2009-12-02 | Medimmune Inc | MODULATORS OF EPHA2 AND EPHRINA1 FOR TREATING A FIBROSIS-ASSOCIATED DISEASE |
| WO2006047639A2 (en) * | 2004-10-27 | 2006-05-04 | Medimmune, Inc. | Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| US20060121043A1 (en) * | 2004-10-27 | 2006-06-08 | Medimmune, Inc. | Use of modulators of EphA2 and EphrinA1 for the treatment and prevention of infections |
| EP1809583A2 (en) * | 2004-11-01 | 2007-07-25 | MedImmune, Inc. | Ultra high throughput capture lift screening methods |
| WO2006081418A2 (en) * | 2005-01-27 | 2006-08-03 | The Burnham Institute | Ephb receptor-binding peptides |
| US20050181479A1 (en) * | 2005-03-04 | 2005-08-18 | Medimmune, Inc. | Periplasmic expression of antibodies using a single signal sequence |
| AU2006304387A1 (en) * | 2005-10-14 | 2007-04-26 | Medimmune, Llc | Cell display of antibody libraries |
-
2005
- 2005-10-18 CA CA002584130A patent/CA2584130A1/en not_active Abandoned
- 2005-10-18 US US11/254,132 patent/US20060121053A1/en not_active Abandoned
- 2005-10-18 AU AU2005295158A patent/AU2005295158A1/en not_active Abandoned
- 2005-10-18 WO PCT/US2005/038237 patent/WO2006045110A2/en not_active Ceased
- 2005-10-18 EP EP05812104A patent/EP1802338A4/en not_active Withdrawn
- 2005-10-18 JP JP2007537041A patent/JP2008516614A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060121053A1 (en) | 2006-06-08 |
| WO2006045110A2 (en) | 2006-04-27 |
| EP1802338A4 (en) | 2010-01-27 |
| EP1802338A2 (en) | 2007-07-04 |
| WO2006045110A3 (en) | 2009-04-09 |
| JP2008516614A (ja) | 2008-05-22 |
| AU2005295158A1 (en) | 2006-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060121053A1 (en) | High cell density process for growth of Listeria | |
| EP2942391B1 (en) | Methods for constructing antibiotic resistance free vaccines | |
| RU2653757C2 (ru) | Модифицированные грамположительные бактерии и их применение | |
| JP2010508861A (ja) | 抗原およびタンパク質毒素をコードする異種ヌクレオチド配列からなる担体としての微生物、その生成方法、ならびにその使用 | |
| US7883696B2 (en) | Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response | |
| KR20190031266A (ko) | 알파바이러스 백신접종을 위한 조성물 및 방법 | |
| KR20060130038A (ko) | 리스테리아에 의거한 EphA2 백신 | |
| JPH04501351A (ja) | 細胞の遺伝的集団において所望の組換え遺伝子を維持する方法 | |
| CN1318105A (zh) | 负调节Osteoprotegerin配体活性的方法 | |
| CN101048181A (zh) | 细菌递送系统 | |
| CN104838004A (zh) | 兼性减毒细菌种类及其制备和使用方法 | |
| KR101291960B1 (ko) | 장내세균에 의한 생물학적 활성제의 제어된 생산 및 전달 | |
| CN101801408A (zh) | 分枝杆菌的电穿孔和抗原在分枝杆菌中的过量表达 | |
| CN1642967A (zh) | 用于传递治疗性化合物的以正常微生物群为基础的临床级载体 | |
| CA3238993A1 (en) | Genetically modified microorganism and use thereof | |
| JP6117212B2 (ja) | 改変されたグラム陽性菌及びその使用 | |
| JP2024542173A (ja) | マクロファージを処置に適している表現型に変換するための免疫刺激細菌および処置のための対象の同定のためのコンパニオン診断法 | |
| CN1216640C (zh) | 人免疫缺陷病毒的活疫苗 | |
| CN103695327A (zh) | 一种口服重组酵母及其介导的靶向肠道DC呈递shRNA的应用 | |
| CN1646020A (zh) | 将核酸和/或蛋白质导入呼吸系统的方法与制剂 | |
| RU2546917C1 (ru) | Способ микробиологического синтеза гибридного белка е7-hsp70 (варианты) | |
| KR101045670B1 (ko) | 돼지 인터류킨-18 유전자를 발현하는 살모넬라 균주 및 이를 함유하는 경구 투여용 조성물 | |
| CN1893972A (zh) | 基于李斯特菌的EphA2疫苗 | |
| EP0358692B1 (en) | Cholera vaccines | |
| WO2000008174A9 (en) | β-CASEIN EXPRESSING CONSTRUCTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20111018 |